Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Xolair in Subjects With Moderate to Severe Persistent Asthma Who Are Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of subcutaneously administered Xolair as add-on therapy for the treatment of subjects aged 12-75 years old diagnosed with moderate to severe asthma who are inadequately controlled with high-dose inhaled corticosteroids (ICS)+ long-acting beta-agonists (LABA) with or without additional controller therapy.


Options:
A: Arm Label: Xolair; Type: EXPERIMENTAL; Interventions: Drug: omalizumab (Xolair), Drug: corticosteroids, Drug: long-acting beta-agonists | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Drug: corticosteroids, Drug: long-acting beta-agonists | Intervention Type: DRUG; Name: omalizumab (Xolair); Assigned to Arm(s): Xolair | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: corticosteroids; Assigned to Arm(s): Xolair, placebo | Intervention Type: DRUG; Name: long-acting beta-agonists; Assigned to Arm(s): Xolair, placebo
B: Arm Label: Omalizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Omalizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
C: Arm Label: Fluticasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone, Drug: montelukast, Drug: Fluticasone plus salmeterol | Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: fluticasone, Drug: montelukast, Drug: Fluticasone plus salmeterol | Arm Label: Fluticasone plus salmeterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone, Drug: montelukast, Drug: Fluticasone plus salmeterol | Intervention Type: DRUG; Name: fluticasone; Assigned to Arm(s): Fluticasone, Fluticasone plus salmeterol, Montelukast | Intervention Type: DRUG; Name: montelukast; Assigned to Arm(s): Fluticasone, Fluticasone plus salmeterol, Montelukast | Intervention Type: DRUG; Name: Fluticasone plus salmeterol; Assigned to Arm(s): Fluticasone, Fluticasone plus salmeterol, Montelukast
D: Arm Label: Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: montelukast (MON), Drug: placebo nasal, Drug: ADVAIR DISKUS | Arm Label: Fluticasone Propionate/Salmeterol (FSC); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: placebo nasal, Drug: ADVAIR DISKUS, Drug: placebo capsule | Arm Label: Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone propionate/salmeterol (FSC), Drug: fluticasone propionate (FP), Drug: ADVAIR DISKUS, Drug: placebo capsule | Arm Label: Montelukast (MON); Type: ACTIVE_COMPARATOR; Interventions: Drug: montelukast (MON), Drug: placebo nasal, Drug: placebo DISKUS | Intervention Type: DRUG; Name: fluticasone propionate/salmeterol (FSC); Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON) | Intervention Type: DRUG; Name: montelukast (MON); Assigned to Arm(s): Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON), Montelukast (MON) | Intervention Type: DRUG; Name: fluticasone propionate (FP); Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS) | Intervention Type: DRUG; Name: placebo nasal; Assigned to Arm(s): Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON), Montelukast (MON) | Intervention Type: DRUG; Name: ADVAIR DISKUS; Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC), Fluticasone Propionate/Salmeterol/Montelukast (FSC+MON) | Intervention Type: DRUG; Name: placebo capsule; Assigned to Arm(s): Fluticasone Prop/Salmeterol/Flut Prop Nasal Spray (FSC+FPANS), Fluticasone Propionate/Salmeterol (FSC) | Intervention Type: DRUG; Name: placebo DISKUS; Assigned to Arm(s): Montelukast (MON)

Answer: A